Tiffany A. Traina, MD

Tiffany A. Traina, MD

I am a board-certified medical oncologist whose clinical practice is dedicated exclusively to the care of patients with all stages of breast cancer. I am part of a large, multidisciplinary team of devoted specialists who share my goal of providing exceptional care to patients fighting breast cancer. Through my research activities, I work to develop new therapeutic options for the treatment of breast cancer and to ultimately eradicate this disease.

My research has centered on the use of novel, targeted therapies for the treatment of triple negative breast cancer (TNBC). Currently, I am the lead investigator for a multicenter trial studying the use of androgen receptor inhibition for patients with advanced TNBC. I have investigated numerous other targets for treatment of this subtype of breast cancer, including src and PARP, and have collaborated to develop biologic predictors of response to conventional therapies such as platinum. I have also had a special interest in optimizing drug delivery schedules to minimize side effects of treatment while maximizing its benefits.

Appointments for New Patients
Clinical Expertise

Breast Cancer

Languages Spoken

MD, Weill Cornell Medical College


NewYork-Presbyterian Hospital/Weill Cornell Medical Center


Memorial Sloan Kettering Cancer Center

Board Certifications

Internal Medicine; Medical Oncology

Publications by Tiffany A. Traina
Visit PubMed for full listing of Tiffany A. Traina journal articles
Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.